Premium
A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes
Author(s) -
Perez Victoria A.,
Husain Sameera,
Magro Cynthia M.,
Strom Mark A.,
Williams Kristen M.,
Levin Laura E.
Publication year - 2020
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.14438
Subject(s) - medicine , insulin pump , insulin , type 1 diabetes , diabetes mellitus , adverse effect , continuous glucose monitoring , pyogenic granuloma , intensive care medicine , dermatology , surgery , endocrinology , lesion
Abstract Continuous subcutaneous insulin infusion (CSII), or insulin pumps, with or without continuous glucose monitoring (CGM) devices have become the standard of care for patients with type 1 diabetes. While increasingly popular, a wide range of reported skin reactions to CSII and CGM devices was found. We present this case of a pyogenic granuloma‐like neutrophilic and granulomatous response to an insulin pump to increase awareness of a previously uncharacterized cutaneous adverse reaction at insulin pump infusion sites.